Frank Schnütgen

10PUBLICATIONS
73CO-AUTHORS
Haematological tumoursMolecular targetsMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 28, 2025
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma.

Deniz Özistanbullu, Raphael Wilhelm, Gabi Reichenbach

|Jun 27, 2024
A Mouse Model of X-Linked Chronic Granulomatous Disease for the Development of CRISPR/Cas9 Gene Therapy.

Seren Sevim-Wunderlich, Tu Dang, Jana Rossius

|Dec 09, 2023
The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival.

Marcel Seibert, Sebastian E Koschade, Verena Stolp

|Nov 07, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia.

Islam Alshamleh, Nina Kurrle, Philipp Makowka

|May 04, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.

Sebastian Scheich, Jiji Chen, Jiamin Liu

|Jan 21, 2022
Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene.

Ada-Sophia Clees, Verena Stolp, Björn Häupl

Pageof 2

Frequent Collaborators

6 joint publications

Hubert Serve

3 joint publications

Bernhard Brüne

3 joint publications

Nina Kurrle

3 joint publications

Thomas Oellerich